Nutritional Supplement

Mistletoe

Parts Used & Where Grown

Mistletoe grows as a partial parasite on a variety of trees—particularly pine, apple, plum, poplar, and spruce—across northern Europe and Asia. The young leafy twigs with flowers are used. Mistletoe’s white berries are potentially toxic and should be avoided. American mistletoe, various species of Phoradendron, are similar but have not been widely studied. They should not be substituted for European mistletoe until more information is available.

How It Works

Several constituents have been shown to contribute to the medicinal action of mistletoe. Most notable are mistletoe lectins (also called viscotoxins), choline derivatives, alkaloids, polypeptides, and polysaccharides. Human pharmacological studies have found that mistletoe extract given by injection stimulates immune system function.1,2,3 Some test tube and animal studies suggest that certain mistletoe constituents, including the alkaloids, can also kill cancer cells.4,5 Numerous clinical trials have found that subcutaneous injections of mistletoe extracts can help people with cancer of various organs, though some have also failed to show any benefit.6,7 There is no evidence that people with cancer would benefit from receiving mistletoe orally.

Mistletoe’s other uses have been less rigorously studied. Preliminary trials carried out using oral mistletoe have found it can reduce the symptoms of high blood pressure, particularly headaches and dizziness.8,9 However, mistletoe has a small (if any) effect on actually lowering blood pressure.10

Test tube and animal studies suggest that mistletoe extracts can stimulate insulin secretion from pancreas cells and may improve blood sugar levels in people with diabetes.11,12 Given both mistletoe’s tradition around the world for helping people with diabetes and these promising preclinical results, human clinical trials are needed to establish mistletoe’s potential for this condition.

References

1. Hajto T. Immunomodulatory effects of Iscador: A Viscum album preparation. Oncology 1986;43(suppl 1):51-65.

2. Bocci B. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review. J Biol Reg Homeostatic Agents 1993;7:1-6.

3. Bloksma N, Schmiermann P, de Reuver M, et al. Stimulation of humoral and cellular immunity by Viscum preparations. Planta Med 1982;46:221-7.

4. Jurin M, Zarkovic' N, Hrzenjak M, Ilic' Z. Antitumorous and immunomodulatory effects of the Viscum album L preparation Isorel. Oncology 1993;50:393-8.

5. Khwaja TA, Dias CB, Pentecost S. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 1986;43(suppl 1):42-50.

6. Yarnell E. Is Viscum album a potential treatment for pancreatic cancer? HealthNotes Review 1999;6:88-90 [review].

7. Kleijnen J, Knipschild P. Mistletoe treatment for cancer. Review of controlled trials in humans. Phytomedicine 1994;1:255-60.

8. Bowman IA. The everlasting mistletoe and the cardiovascular system. Texas Heart Inst J 1990;17:310–4.

9. O'Hare JP, Hoyt LH. Mistletoe in the treatment of hypertension. New Eng J Med 1928;199:1207-13.

10. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158-60.

11. Gray AM, Flatt PR. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J Endocrinol 1999;160:409-14.

12. Swanson-Flatt SK, Day C, Bailey CJ, Flatt PR. Evaluation of traditional plant treatments for diabetes: Studies in streptozotocin-diabetic mice. Acta Diabetologica Latina 1989;26:51-5.

13. Aldawsari H, Hanafy A, Labib G, Badr J. Antihyperglycemic activities of extracts of the mistletoes Plicosepalus acaciae and P. curviflorus in comparison to their solid lipid nanoparticle suspension formulations. Z Naturforsch C 2014;69:391–8.

14. Abdallah H, Farag M, Abdel-Naim A, et al. Mechanistic Evidence of Viscum schimperi (Viscaceae) Antihyperglycemic Activity: From a Bioactivity-guided Approach to Comprehensive Metabolite Profiling. Phytother Res 2015;29:1737–43.

15. Ko B, Kang S, Moon B, et al. A 70% Ethanol Extract of Mistletoe Rich in Betulin, Betulinic Acid, and Oleanolic Acid Potentiated beta-Cell Function and Mass and Enhanced Hepatic Insulin Sensitivity. Evid Based Complement Alternat Med 2016;2016:7836823.

16. Park J, Kim Y, Kim J, et al. Viscothionin purified from mistletoe (Viscum album var. coloratum Ohwi) induces insulin secretion from pancreatic beta cells. J Ethnopharmacol 2019;234:172–9.

17. Abdallah H, Farag M, Abdel-Naim A, et al. Mechanistic Evidence of Viscum schimperi (Viscaceae) Antihyperglycemic Activity: From a Bioactivity-guided Approach to Comprehensive Metabolite Profiling. Phytother Res 2015;29:1737–43.

18. Eno A, Ofem O, Nku C, et al. Stimulation of insulin secretion by Viscum album (mistletoe) leaf extract in streptozotocin-induced diabetic rats. Afr J Med Med Sci 2008;37:141–7.

19. Turkkan A, Savas H, Yavuz B, et al. The prophylactic effect of Viscum album in streptozotocin-induced diabetic rats. North Clin Istanb 2016;3:83–9.

20. Nazaruk J, Orlikowski P. Phytochemical profile and therapeutic potential of Viscum album L. Nat Prod Res 2016;30:373–85.

21. Khan T, Ali S, Qayyum R, et al. Intestinal and vascular smooth muscle relaxant effect of Viscum album explains its medicinal use in hyperactive gut disorders and hypertension. BMC Complement Altern Med 2016;16:251.

22. Poruthukaren KJ, Palatty PL, Baliga MS, et al. Clinical evaluation of Viscum album mother tincture as an antihypertensive: a pilot study. J Evid Based Complementary Altern Med 2014;19:31–5.

23. Bowman IA. The everlasting mistletoe and the cardiovascular system. Texas Heart Inst J 1990;17:310–4.

24. Gorter R, Khwaja T, Linder M. Anti-HIV and immunomodulating activities of Viscum album (mistletoe). Int Conf AIDS 1992;8:84 [abstract no. PuB 7214].

25. Gorter R, Stoss M, el Arif N, et al. Immune modulating and anti-HIV activities of Viscum album (Iscador). Int Conf AIDS 1993;9:496 [abstract no. PO-B28-2167].

26. Walker BG. The Woman's Encyclopedia of Myths and Secrets. San Francisco: Harper & Row, 1983, 661-3.

27. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 512-3.

28. Urech K. Mistletoe constituents and cancer therapy. J Anthroposophical Med 1993;10:54-63.

29. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158-60.

30. Weiss RF. Herbal Medicine. Gothenburg, Sweden: Ab Arcanum and Beaconsfield, UK: Beaconsfield Publishers Ltd, 1985, 158-60.

31. Krenzelok EP, Jacobsen TD, Aronis J. American mistletoe exposures. Am J Emerg Med 1997;15:516-20.

32. Spiller HA, Willias DB, Gorman SE, Sanftleban J. Retrospective study of mistletoe ingestion. Clin Toxicol 1996;34:405-8.

33. Bauer C, Oppel T, Rueff F, Przybilla B. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts. Ann Allergy Asthma Immunol 2005;94:86-9.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.